N.Y. U.S. Attorney: Two Individuals, Including a Former Pharmaceutical Executive, Plead Guilty to Participating in Insider Trading Scheme Surrounding Alexion Pharmaceuticals' Acquisition of Portola Pharmaceuticals
According to the allegations in the Indictment and statements made in public court proceedings:
In 2020, DUPONT, KAPLAN, and others engaged in an insider trading scheme surrounding the announcement of Alexion's acquisition of Portola. DUPONT was a vice president at Alexion and, on
In turn, DUPONT's friend provided KAPLAN, who was also known to DUPONT, the MNPI about Portola's pending acquisition, both so that KAPLAN could trade in advance of the acquisition and so that KAPLAN would assist DUPONT's friend in formulating trading strategies to maximize DUPONT's friend's own trading profits. KAPLAN further shared MNPI about the upcoming acquisition with a family member and a friend and colleague. After Alexion's acquisition of Portola was publicly announced on the morning of
* * *
DUPONT, 44, of
The maximum potential sentence is prescribed by
This case is being handled by the Office's
* * *
Original text here: https://www.justice.gov/usao-sdny/pr/two-individuals-including-former-pharmaceutical-executive-plead-guilty-participating
Former congressman sentenced to 22 months in prison for insider trading
Ex-Deutsche Bank investment banker pleads guilty to crypto fraud
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News